Expression profiling of leukemia patients: Key lessons and future directions

Golub, 1999, Molecular classification of cancer: class discovery and class prediction by gene expression monitoring, Science, 286, 531, 10.1126/science.286.5439.531 Chen, 2010, Leukaemogenesis: more than mutant genes, Nat Rev Cancer, 10, 23, 10.1038/nrc2765 Estey, 2006, Acute myeloid leukaemia, Lancet, 368, 1894, 10.1016/S0140-6736(06)69780-8 Bullinger, 2005, Gene expression profiling in acute myeloid leukemia, J Clin Oncol, 23, 6296, 10.1200/JCO.2005.05.020 Theilgaard-Monch, 2011, Gene expression profiling in MDS and AML: potential and future avenues, Leukemia, 25, 909, 10.1038/leu.2011.48 Wouters, 2009, A decade of genome-wide gene expression profiling in acute myeloid leukemia: flashback and prospects, Blood, 113, 291, 10.1182/blood-2008-04-153239 Bacher, 2009, Gene expression profiling in acute myeloid leukaemia (AML), Best Pract Res Clin Haematol, 22, 169, 10.1016/j.beha.2009.04.003 Bullinger, 2004, Use of gene-expression profiling to identify prognostic subclasses in adult acute myeloid leukemia, N Engl J Med, 350, 1605, 10.1056/NEJMoa031046 Bullinger, 2007, Gene-expression profiling identifies distinct subclasses of core binding factor acute myeloid leukemia, Blood, 110, 1291, 10.1182/blood-2006-10-049783 Luck, 2010, KIT mutations confer a distinct gene expression signature in core binding factor leukaemia, Br J Haematol, 148, 925, 10.1111/j.1365-2141.2009.08035.x Valk, 2004, Prognostically useful gene-expression profiles in acute myeloid leukemia, N Engl J Med, 350, 1617, 10.1056/NEJMoa040465 Wilson, 2006, Gene expression profiling of adult acute myeloid leukemia identifies novel biologic clusters for risk classification and outcome prediction, Blood, 108, 685, 10.1182/blood-2004-12-4633 Wouters, 2009, Double CEBPA mutations, but not single CEBPA mutations, define a subgroup of acute myeloid leukemia with a distinctive gene expression profile that is uniquely associated with a favorable outcome, Blood, 113, 3088, 10.1182/blood-2008-09-179895 Haferlach, 2010, Clinical utility of microarray-based gene expression profiling in the diagnosis and subclassification of leukemia: report from the International Microarray Innovations in Leukemia Study Group, J Clin Oncol, 28, 2529, 10.1200/JCO.2009.23.4732 Li, 2012, Up-regulation of a HOXA-PBX3 homeobox-gene signature following down-regulation of miR-181 is associated with adverse prognosis in patients with cytogenetically abnormal AML, Blood, 119, 2314, 10.1182/blood-2011-10-386235 Bullinger, 2004, Use of gene-expression profiling to identify prognostic subclasses in adult acute myeloid leukemia, N Engl J Med, 350, 1605, 10.1056/NEJMoa031046 Garzon, 2008, Distinctive microRNA signature of acute myeloid leukemia bearing cytoplasmic mutated nucleophosmin, Proc Natl Acad Sci U S A, 105, 3945, 10.1073/pnas.0800135105 Verhaak, 2005, Mutations in nucleophosmin (NPM1) in acute myeloid leukemia (AML): association with other gene abnormalities and previously established gene expression signatures and their favorable prognostic significance, Blood, 106, 3747, 10.1182/blood-2005-05-2168 Wouters, 2007, Distinct gene expression profiles of acute myeloid/T-lymphoid leukemia with silenced CEBPA and mutations in NOTCH1, Blood, 110, 3706, 10.1182/blood-2007-02-073486 Bullinger, 2008, An FLT3 gene-expression signature predicts clinical outcome in normal karyotype AML, Blood, 111, 4490, 10.1182/blood-2007-09-115055 Marcucci, 2010, IDH1 and IDH2 gene mutations identify novel molecular subsets within de novo cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study, J Clin Oncol, 28, 2348, 10.1200/JCO.2009.27.3730 Metzeler, 2011, TET2 mutations improve the new European LeukemiaNet risk classification of acute myeloid leukemia: a Cancer and Leukemia Group B study, J Clin Oncol, 29, 1373, 10.1200/JCO.2010.32.7742 Gaidzik, 2012, TET2 mutations in acute myeloid leukemia (AML): results from a comprehensive genetic and clinical analysis of the AML study group, J Clin Oncol, 30, 1350, 10.1200/JCO.2011.39.2886 Metzeler, 2011, ASXL1 mutations identify a high-risk subgroup of older patients with primary cytogenetically normal AML within the ELN Favorable genetic category, Blood, 118, 6920, 10.1182/blood-2011-08-368225 Gaidzik, 2011, RUNX1 mutations in acute myeloid leukemia: results from a comprehensive genetic and clinical analysis from the AML study group, J Clin Oncol, 29, 1364, 10.1200/JCO.2010.30.7926 Kohlmann, 2010, Gene expression profiling in AML with normal karyotype can predict mutations for molecular markers and allows novel insights into perturbed biological pathways, Leukemia, 24, 1216, 10.1038/leu.2010.73 Radmacher, 2006, Independent confirmation of a prognostic gene-expression signature in adult acute myeloid leukemia with a normal karyotype: a Cancer and Leukemia Group B study, Blood, 108, 1677, 10.1182/blood-2006-02-005538 Metzeler, 2008, An 86-probe-set gene-expression signature predicts survival in cytogenetically normal acute myeloid leukemia, Blood, 112, 4193, 10.1182/blood-2008-02-134411 Li, 2013, Identification of a 24-gene prognostic signature that improves the European LeukemiaNet risk classification of acute myeloid leukemia: an international collaborative study, J Clin Oncol, 31, 1172, 10.1200/JCO.2012.44.3184 Lacayo, 2004, Gene expression profiles at diagnosis in de novo childhood AML patients identify FLT3 mutations with good clinical outcomes, Blood, 104, 2646, 10.1182/blood-2003-12-4449 Bresolin, 2010, Gene expression-based classification as an independent predictor of clinical outcome in juvenile myelomonocytic leukemia, J Clin Oncol, 28, 1919, 10.1200/JCO.2009.24.4426 Eppert, 2011, Stem cell gene expression programs influence clinical outcome in human leukemia, Nat Med, 17, 1086, 10.1038/nm.2415 Metzeler, 2013, A stem cell-like gene expression signature associates with inferior outcomes and a distinct microRNA expression profile in adults with primary cytogenetically normal acute myeloid leukemia, Leukemia, 27, 2023, 10.1038/leu.2013.181 Miller, 2010, Integrative meta-analysis of differential gene expression in acute myeloid leukemia, PLoS One, 5, e9466, 10.1371/journal.pone.0009466 Papaemmanuil, 2011, Somatic SF3B1 mutation in myelodysplasia with ring sideroblasts, N Engl J Med, 365, 1384, 10.1056/NEJMoa1103283 Yoshida, 2011, Frequent pathway mutations of splicing machinery in myelodysplasia, Nature, 478, 64, 10.1038/nature10496 Makishima, 2012, Mutations in the spliceosome machinery, a novel and ubiquitous pathway in leukemogenesis, Blood, 119, 3203, 10.1182/blood-2011-12-399774 Dolnik, 2012, Commonly altered genomic regions in acute myeloid leukemia are enriched for somatic mutations involved in chromatin remodeling and splicing, Blood, 120, e83, 10.1182/blood-2011-12-401471 Dallosso, 2007, Alternately spliced WT1 antisense transcripts interact with WT1 sense RNA and show epigenetic and splicing defects in cancer, RNA, 13, 2287, 10.1261/rna.562907 Adamia, 2014, A genome-wide aberrant RNA splicing in patients with acute myeloid leukemia identifies novel potential disease markers and therapeutic targets, Clin Cancer Res, 20, 1135, 10.1158/1078-0432.CCR-13-0956 Sammeth, 2008, A general definition and nomenclature for alternative splicing events, PLoS Comput Biol, 4, e1000147, 10.1371/journal.pcbi.1000147 Adamia, 2014, NOTCH2 and FLT3 gene mis-splicing are common events in patients with acute myeloid leukemia (AML): new potential targets in AML, Blood, 123, 2816, 10.1182/blood-2013-02-481507 Brooks, 2014, A pan-cancer analysis of transcriptome changes associated with somatic mutations in U2AF1 reveals commonly altered splicing events, PLoS One, 9, e87361, 10.1371/journal.pone.0087361 Przychodzen, 2013, Patterns of missplicing due to somatic U2AF1 mutations in myeloid neoplasms, Blood, 122, 999, 10.1182/blood-2013-01-480970 Bernstein, 2012, An integrated encyclopedia of DNA elements in the human genome, Nature, 489, 57, 10.1038/nature11247 Bartel, 2004, MicroRNAs: genomics, biogenesis, mechanism, and function, Cell, 116, 281, 10.1016/S0092-8674(04)00045-5 Bartel, 2009, MicroRNAs: Target recognition and regulatory functions, Cell, 136, 215, 10.1016/j.cell.2009.01.002 Raghavachari, 2014, Integrated analysis of miRNA and mRNA during differentiation of human CD34+ cells delineates the regulatory roles of microRNA in hematopoiesis, Exp Hematol, 42, 14, 10.1016/j.exphem.2013.10.003 Havelange, 2009, MicroRNAs: New players in acute myeloid leukaemia, Br J Cancer, 101, 743, 10.1038/sj.bjc.6605232 Wieser, 2010, MicroRNAs in acute myeloid leukemia: expression patterns, correlations with genetic and clinical parameters, and prognostic significance, Genes Chromosomes Cancer, 49, 193 Marcucci, 2011, The prognostic and functional role of microRNAs in acute myeloid leukemia, Blood, 117, 1121, 10.1182/blood-2010-09-191312 Lu, 2005, MicroRNA expression profiles classify human cancers, Nature, 435, 834, 10.1038/nature03702 Li, 2008, Distinct microRNA expression profiles in acute myeloid leukemia with common translocations, Proc Natl Acad Sci U S A, 105, 15535, 10.1073/pnas.0808266105 Jongen-Lavrencic, 2008, MicroRNA expression profiling in relation to the genetic heterogeneity of acute myeloid leukemia, Blood, 111, 5078, 10.1182/blood-2008-01-133355 Dixon-McIver, 2008, Distinctive patterns of microRNA expression associated with karyotype in acute myeloid leukaemia, PLoS One, 3, e2141, 10.1371/journal.pone.0002141 Marcucci, 2008, MicroRNA expression in cytogenetically normal acute myeloid leukemia, N Engl J Med, 358, 1919, 10.1056/NEJMoa074256 Russ, 2011, Integrative nucleophosmin mutation-associated microRNA and gene expression pattern analysis identifies novel microRNA–target gene interactions in acute myeloid leukemia, Haematologica, 96, 1783, 10.3324/haematol.2011.046888 Garzon, 2008, MicroRNA signatures associated with cytogenetics and prognosis in acute myeloid leukemia, Blood, 111, 3183, 10.1182/blood-2007-07-098749 Marcucci, 2008, Prognostic significance of, and gene and microRNA expression signatures associated with, CEBPA mutations in cytogenetically normal acute myeloid leukemia with high-risk molecular features: a Cancer and Leukemia Group B Study, J Clin Oncol, 26, 5078, 10.1200/JCO.2008.17.5554 Pulikkan, 2010, C/EBPalpha regulated microRNA-34a targets E2F3 during granulopoiesis and is down-regulated in AML with CEBPA mutations, Blood, 116, 5638, 10.1182/blood-2010-04-281600 Mendler, 2012, RUNX1 mutations are associated with poor outcome in younger and older patients with cytogenetically normal acute myeloid leukemia and with distinct gene and MicroRNA expression signatures, J Clin Oncol, 30, 3109, 10.1200/JCO.2011.40.6652 Marcucci, 2012, Age-related prognostic impact of different types of DNMT3A mutations in adults with primary cytogenetically normal acute myeloid leukemia, J Clin Oncol, 30, 742, 10.1200/JCO.2011.39.2092 Langer, 2009, Prognostic importance of MN1 transcript levels, and biologic insights from MN1-associated gene and microRNA expression signatures in cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study, J Clin Oncol, 27, 3198, 10.1200/JCO.2008.20.6110 Schwind, 2010, Prognostic significance of expression of a single microRNA, miR-181a, in cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study, J Clin Oncol, 28, 5257, 10.1200/JCO.2010.29.2953 Zhang, 2009, MicroRNA patterns associated with clinical prognostic parameters and CNS relapse prediction in pediatric acute leukemia, PLoS One, 4, e7826, 10.1371/journal.pone.0007826 Marcucci, 2013, Clinical role of microRNAs in cytogenetically normal acute myeloid leukemia: miR-155 upregulation independently identifies high-risk patients, J Clin Oncol, 31, 2086, 10.1200/JCO.2012.45.6228 Diaz-Beya, 2014, MicroRNA expression at diagnosis adds relevant prognostic information to molecular categorization in patients with intermediate-risk cytogenetic acute myeloid leukemia, Leukemia, 28, 804, 10.1038/leu.2013.281 Grasedieck, 2013, Circulating microRNAs in hematological diseases: principles, challenges, and perspectives, Blood, 121, 4977, 10.1182/blood-2013-01-480079 Grasedieck, 2012, Impact of serum storage conditions on microRNA stability, Leukemia, 26, 2414, 10.1038/leu.2012.106 Fayyad-Kazan, 2013, Circulating miR-150 and miR-342 in plasma are novel potential biomarkers for acute myeloid leukemia, J Transl Med, 11, 31, 10.1186/1479-5876-11-31 Tanaka, 2009, Down-regulation of miR-92 in human plasma is a novel marker for acute leukemia patients, PLoS One, 4, e5532, 10.1371/journal.pone.0005532 Zhi, 2013, Identification of circulating microRNAs as potential biomarkers for detecting acute myeloid leukemia, PLoS One, 8, e56718, 10.1371/journal.pone.0056718 Kuchenbauer, 2011, Comprehensive analysis of mammalian miRNA* species and their role in myeloid cells, Blood, 118, 3350, 10.1182/blood-2010-10-312454 Garitano-Trojaola, 2013, Long non-coding RNAs in haematological malignancies, Int J Mol Sci, 14, 15386, 10.3390/ijms140815386 Memczak, 2013, Circular RNAs are a large class of animal RNAs with regulatory potency, Nature, 495, 333, 10.1038/nature11928 Bamezai, 2012, Concise review: The Piwi–piRNA axis: Pivotal beyond transposon silencing, Stem Cells, 30, 2603, 10.1002/stem.1237 Tay, 2014, The multilayered complexity of ceRNA crosstalk and competition, Nature, 505, 344, 10.1038/nature12986 Mardis, 2009, Recurring mutations found by sequencing an acute myeloid leukemia genome, N Engl J Med, 361, 1058, 10.1056/NEJMoa0903840 Wang, 2009, RNA-Seq: a revolutionary tool for transcriptomics, Nat Rev Genet, 10, 57, 10.1038/nrg2484 Ozsolak, 2011, RNA sequencing: advances, challenges and opportunities, Nat Rev Genet, 12, 87, 10.1038/nrg2934 Battke, 2011, Mayday SeaSight: combined analysis of deep sequencing and microarray data, PLoS One, 6, e16345, 10.1371/journal.pone.0016345 Miller, 2013, Genomic landscapes and clonality of de novo AML, N Engl J Med, 369, 1473 Figueroa, 2010, DNA methylation signatures identify biologically distinct subtypes in acute myeloid leukemia, Cancer Cell, 17, 13, 10.1016/j.ccr.2009.11.020 Bullinger, 2010, Quantitative DNA methylation predicts survival in adult acute myeloid leukemia, Blood, 115, 636, 10.1182/blood-2009-03-211003 Marcucci, 2014, Epigenetics meets genetics in acute myeloid leukemia: clinical impact of a novel seven-gene score, J Clin Oncol, 32, 548, 10.1200/JCO.2013.50.6337 Hebestreit, 2013, Detection of significantly differentially methylated regions in targeted bisulfite sequencing data, Bioinformatics, 29, 1647, 10.1093/bioinformatics/btt263 Joshi, 2013, Gene set control analysis predicts hematopoietic control mechanisms from genome-wide transcription factor binding data, Exp Hematol, 41, 354, 10.1016/j.exphem.2012.11.008 Welch, 2012, The origin and evolution of mutations in acute myeloid leukemia, Cell, 150, 264, 10.1016/j.cell.2012.06.023 Jan, 2012, Clonal evolution of preleukemic hematopoietic stem cells precedes human acute myeloid leukemia, Sci Transl Med, 4, 149ra18, 10.1126/scitranslmed.3004315 Ding, 2012, Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing, Nature, 481, 506, 10.1038/nature10738 Shackleton, 2009, Heterogeneity in cancer: cancer stem cells versus clonal evolution, Cell, 138, 822, 10.1016/j.cell.2009.08.017 Bendall, 2012, From single cells to deep phenotypes in cancer, Nat Biotechnol, 30, 639, 10.1038/nbt.2283 Moignard, 2013, Characterization of transcriptional networks in blood stem and progenitor cells using high-throughput single-cell gene expression analysis, Nat Cell Biol, 15, 363, 10.1038/ncb2709 Guo, 2013, Mapping cellular hierarchy by single-cell analysis of the cell surface repertoire, Cell Stem Cell, 13, 492, 10.1016/j.stem.2013.07.017 Schwind, 2011, Low expression of MN1 associates with better treatment response in older patients with de novo cytogenetically normal acute myeloid leukemia, Blood, 118, 4188, 10.1182/blood-2011-06-357764 Schwind, 2010, BAALC and ERG expression levels are associated with outcome and distinct gene and microRNA expression profiles in older patients with de novo cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study, Blood, 116, 5660, 10.1182/blood-2010-06-290536